ARCHIVES

Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

Tests Find No Conclusive Evidence On Two Chemicals

September 21, 1979

Darbepoetin Didn’t Decrease Blood Transfusions, Lowered Overall Survival, Study Finds

April 27, 2007

House May Add $80 Million To NCI Budget For FY 1984

September 16, 1983

NCI’s Supercomputer Undergoing Testing

April 11, 1986

Women’s Health Trial RFPs Issued; Three Clinical Centers Sought

April 12, 1991

ASCO Backs Central IRB For Cancer Trials, Stiffens Conflict-of-Interest Policies

May 2, 2003